Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Lyall DA, Tey A, Foot B, Roxburgh ST, Virdi M, Robertson C et al. Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye (London, England) 2012; 26 (12): 1517–1526.
Day S, Acquah K, Mruthyunjaya P, Grossman DS, Lee PP, Sloan FA . Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration. Am J Ophthalmol 2011; 152 (2): 266–272.
McCannel CA . Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina (Philadelphia, PA) 2011; 31 (4): 654–661.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Alexander, P., Sahu, D. & Lotery, A. Subconjunctival anaesthesia for intravitreal injections. Eye 27, 1109 (2013). https://doi.org/10.1038/eye.2013.132
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2013.132
